Cannabinoid Use in Pediatric Epilepsy

dc.contributor.authorWhitney, Robynen_US
dc.contributor.authorJauhari, Prashanten_US
dc.contributor.authorJain, Puneeten_US
dc.date.accessioned2025-08-13T09:09:40Z
dc.date.available2025-08-13T09:09:40Z
dc.date.issued2025-04
dc.description.abstractCannabidiol has shown promising effects on reducing seizure frequency in children and adults with selected epilepsy syndromes. In this narra?ve brief review, we provide an update on the use of cannabidiol in pediatric epilepsy including theindica?ons for its use, clinical efficacy, adverse effects, requirements for monitoring and regula?ons.en_US
dc.identifier.affiliationsDivision of Neurology, Department of Pediatrics, McMaster University, Hamilton, ON, Canadaen_US
dc.identifier.affiliationsChild Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi, Indiaen_US
dc.identifier.affiliationsEpilepsy Program, Division of Neurology, Department of Pediatrics, Hospital for Sick Children (HSC), University of Toronto, Toronto, ON, Canada.en_US
dc.identifier.citationWhitney Robyn, Jauhari Prashant, Jain Puneet . Cannabinoid Use in Pediatric Epilepsy. Indian Pediatrics. 2025 Apr; 62(4): 300-305en_US
dc.identifier.issn0019-6061
dc.identifier.issn0974-7559
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/251336
dc.languageenen_US
dc.publisherIndian Academy of Pediatricsen_US
dc.relation.issuenumber4en_US
dc.relation.volume62en_US
dc.source.urihttps://indianpediatrics.net/apr2025/300.pdfen_US
dc.subjectCBDen_US
dc.subjectTetrahydrocannabiniolen_US
dc.subjectLennox Gastuat syndromeen_US
dc.subjectDravet syndromeen_US
dc.subjectTuberous sclerosis complexen_US
dc.titleCannabinoid Use in Pediatric Epilepsyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ip2025v62n4p300.pdf
Size:
125.52 KB
Format:
Adobe Portable Document Format